By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global ...

Robotic company RIVR plans to put robo delivery dogs to deliver grocery items, parcels, packages and fresh meals in the near ...

Vascular toxicity associated with cancer therapies is a leading cause of cardiovascular adverse events in patients with ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

H LUNDBECK A/S (($HLUYY)) announced an update on their ongoing clinical study. H. Lundbeck A/S is currently conducting a clinical trial titled ...

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...

The vaccine would train the immune system to fight cancer-causing mutations, according to new research from UCLA Health.

A new 'off-the-shelf' vaccine with the catchy name ELI-002 2P offers fresh hope for individuals affected by these deadly ...

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight ...

As part of the treatment trial, Jay does chemotherapy every other week for six months. Access to clinical trials is offered ...